Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran
Q Ji, Q Xu, Z Wang, X Li, Q Lv - European Journal of Clinical …, 2019 - Springer
Purpose The purpose of this study was to analyze the association between bleeding events
and coagulation assays including activated partial thromboplastin time (APTT) and …
and coagulation assays including activated partial thromboplastin time (APTT) and …
Dabigatran in clinical practice for atrial fibrillation with special reference to activated partial thromboplastin time
S Suzuki, T Otsuka, K Sagara, S Matsuno… - Circulation …, 2012 - jstage.jst.go.jp
Background: The distribution of activated partial thromboplastin time (APTT) in nonvalvular
atrial fibrillation (NVAF) patients under dabigatran therapy remains to be clarified. Methods …
atrial fibrillation (NVAF) patients under dabigatran therapy remains to be clarified. Methods …
[HTML][HTML] Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice
M Kawabata, Y Yokoyama, T Sasano, H Hachiya… - Journal of …, 2013 - Elsevier
Background Dabigatran has demonstrated promising results for the prevention of strokes in
patients with non-valvular atrial fibrillation (NVAF). However, there have been episodes of …
patients with non-valvular atrial fibrillation (NVAF). However, there have been episodes of …
Assessment of predicted rate and associated factors of dabigatran-induced bleeding events in Malaysian patients with non-valvular atrial fibrillation
SA Beshir, LB Yap, S Sim… - Journal of Pharmacy …, 2017 - journals.library.ualberta.ca
Purpose: To assess the predicted rate and the factors associated with bleeding events
among patients with non-valvular atrial fibrillation (NVAF) receiving dabigatran therapy …
among patients with non-valvular atrial fibrillation (NVAF) receiving dabigatran therapy …
Peripheral leukocyte count and risk of bleeding in patients with non-valvular atrial fibrillation taking dabigatran: a real-world study
W Zhou, T Wang, LJ Zhu, MH Wen, LH Hu… - Chinese Medical …, 2019 - mednexus.org
Background: The association between peripheral leukocyte count and bleeding events in
nonvalvular atrial fibrillation (NVAF) patients treated with dabigatran remains unclear. This …
nonvalvular atrial fibrillation (NVAF) patients treated with dabigatran remains unclear. This …
Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
Y Liu, Q Xie, Z Liu, Z Wang, G Mu, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
We aimed to develop a pharmacokinetic (PK) and pharmacodynamic (PD) model from
healthy Chinese subjects and real-world non-valvular atrial fibrillation (NVAF) patients. We …
healthy Chinese subjects and real-world non-valvular atrial fibrillation (NVAF) patients. We …
[HTML][HTML] Frequency and predictors of bleeding complications associated with anti-coagulant therapy using dabigatran in Japanese patients with atrial fibrillation
H Katoh, T Nozue, T Asada, K Nakashima… - American Journal of …, 2014 - ncbi.nlm.nih.gov
Background: Few data exist regarding frequency and predictors of bleeding complications
associated with anticoagulant therapy using dabigatran in Japanese patients with atrial …
associated with anticoagulant therapy using dabigatran in Japanese patients with atrial …
[HTML][HTML] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
D Shimomura, Y Nakagawa, H Kondo, T Tamura… - Journal of …, 2015 - Elsevier
Background Activated partial thromboplastin time (aPTT) is recommended for monitoring
anticoagulant activity in dabigatran-treated patients; however, there are limited data in …
anticoagulant activity in dabigatran-treated patients; however, there are limited data in …
Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests
HJ Cho, YJ Kang, SM Sung, SH Ahn, YH Jung, KY Lee… - PloS one, 2020 - journals.plos.org
Introduction Prior use of direct oral anticoagulants has been associated with reduced stroke
severity in patients with non-valvular atrial fibrillation (NVAF). The aim of this study was to …
severity in patients with non-valvular atrial fibrillation (NVAF). The aim of this study was to …
Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation
Z Zhu, Z Shen, A Shi, C Su, J Mao, H Tao, F Xu, Z Hu… - Heart and Vessels, 2022 - Springer
This study aimed to evaluate the variability of dabigatran plasma concentration and the
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
相关搜索
- thromboplastin time bleeding events
- thromboplastin time clinical practice
- nvaf patients bleeding events
- thromboplastin time nvaf patients
- thromboplastin time atrial fibrillation
- predicted rate bleeding events
- dabigatran etexilate chinese patients
- associated factors bleeding events
- clinical practice bleeding events
- bleeding complications japanese patients
- malaysian patients bleeding events
- thromboplastin time japanese patients